14159 capital gp llc - through partnership investment history in Idera pharmaceuticals inc

Filed on 2008-09-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4/a

Accession 0001144204-08-055349.txt Sec File: edgar/data/1317493/0001144204-08-055349-index.htm

2008-07-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 182 shares at $14.8726 remaining shares owned 13473

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-09-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4/a

Accession 0001144204-08-055349.txt Sec File: edgar/data/1317493/0001144204-08-055349-index.htm

2008-07-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 606 shares at $14.931 remaining shares owned 12867

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-042890.txt Sec File: edgar/data/1317493/0001144204-08-042890-index.htm

2008-07-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 606 shares at $14.931 remaining shares owned 12867

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-042890.txt Sec File: edgar/data/1317493/0001144204-08-042890-index.htm

2008-07-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 182 shares at $14.8726 remaining shares owned 13473

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-25 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-041966.txt Sec File: edgar/data/1317493/0001144204-08-041966-index.htm

2008-07-25 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 568 shares at $15.0117 remaining shares owned 13655

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-25 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-041966.txt Sec File: edgar/data/1317493/0001144204-08-041966-index.htm

2008-07-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 945 shares at $15.021 remaining shares owned 14223

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-25 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-041966.txt Sec File: edgar/data/1317493/0001144204-08-041966-index.htm

2008-07-23 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 605 shares at $14.859 remaining shares owned 15168

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-21 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-040974.txt Sec File: edgar/data/1317493/0001144204-08-040974-index.htm

2008-07-17 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 1136 shares at $14.8 remaining shares owned 15773

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-16 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-040322.txt Sec File: edgar/data/1317493/0001144204-08-040322-index.htm

2008-07-14 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 527 shares at $15.2412 remaining shares owned 16909

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-037986.txt Sec File: edgar/data/1317493/0001144204-08-037986-index.htm

2008-07-01 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 302 shares at $14.5135 remaining shares owned 17436

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-037986.txt Sec File: edgar/data/1317493/0001144204-08-037986-index.htm

2008-06-30 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 776 shares at $14.9927 remaining shares owned 17738

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-07-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-037986.txt Sec File: edgar/data/1317493/0001144204-08-037986-index.htm

2008-06-27 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 10207 shares at $15.41 remaining shares owned 18514

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-14 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-002162.txt Sec File: edgar/data/1317493/0001144204-08-002162-index.htm

2008-01-10 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 13 shares at $13.0028 remaining shares owned 28721

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-09 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-001410.txt Sec File: edgar/data/1317493/0001144204-08-001410-index.htm

2008-01-09 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 68 shares at $13.0008 remaining shares owned 28734

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-09 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-001410.txt Sec File: edgar/data/1317493/0001144204-08-001410-index.htm

2008-01-08 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 3 shares at $13 remaining shares owned 28802

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-09 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-001410.txt Sec File: edgar/data/1317493/0001144204-08-001410-index.htm

2008-01-07 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 3 shares at $13 remaining shares owned 28805

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-000803.txt Sec File: edgar/data/1317493/0001144204-08-000803-index.htm

2008-01-04 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 332 shares at $13.143 remaining shares owned 28808

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-000803.txt Sec File: edgar/data/1317493/0001144204-08-000803-index.htm

2008-01-03 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 317 shares at $13.2923 remaining shares owned 29140

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2008-01-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-08-000803.txt Sec File: edgar/data/1317493/0001144204-08-000803-index.htm

2008-01-02 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 945 shares at $12.9432 remaining shares owned 29457

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-067233.txt Sec File: edgar/data/1317493/0001144204-07-067233-index.htm

2007-12-12 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 3 shares at $12.25 remaining shares owned 30402

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-067233.txt Sec File: edgar/data/1317493/0001144204-07-067233-index.htm

2007-12-11 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 85 shares at $12.2527 remaining shares owned 30405

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-12 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-067233.txt Sec File: edgar/data/1317493/0001144204-07-067233-index.htm

2007-12-10 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 192 shares at $12.3641 remaining shares owned 30490

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-07 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-066520.txt Sec File: edgar/data/1317493/0001144204-07-066520-index.htm

2007-12-06 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 777 shares at $12.3531 remaining shares owned 30931

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-07 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-066520.txt Sec File: edgar/data/1317493/0001144204-07-066520-index.htm

2007-12-07 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 249 shares at $12.2547 remaining shares owned 30682

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-07 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-066520.txt Sec File: edgar/data/1317493/0001144204-07-066520-index.htm

2007-12-05 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 381 shares at $12.284 remaining shares owned 31708

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-065760.txt Sec File: edgar/data/1317493/0001144204-07-065760-index.htm

2007-12-04 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 443 shares at $12.2057 remaining shares owned 32089

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-065760.txt Sec File: edgar/data/1317493/0001144204-07-065760-index.htm

2007-12-03 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 756 shares at $12.1609 remaining shares owned 32532

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-12-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-065760.txt Sec File: edgar/data/1317493/0001144204-07-065760-index.htm

2007-11-30 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 546 shares at $12.0303 remaining shares owned 33288

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-21 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-063947.txt Sec File: edgar/data/1317493/0001144204-07-063947-index.htm

2007-11-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 42 shares at $11.8016 remaining shares owned 33834

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-15 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-062311.txt Sec File: edgar/data/1317493/0001144204-07-062311-index.htm

2007-11-15 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 814 shares at $11.7748 remaining shares owned 33876

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-15 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-062311.txt Sec File: edgar/data/1317493/0001144204-07-062311-index.htm

2007-11-14 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 174 shares at $12.0509 remaining shares owned 34690

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-15 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-062311.txt Sec File: edgar/data/1317493/0001144204-07-062311-index.htm

2007-11-13 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 247 shares at $12.0215 remaining shares owned 34864

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-08 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-059382.txt Sec File: edgar/data/1317493/0001144204-07-059382-index.htm

2007-11-08 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 318 shares at $12.7217 remaining shares owned 35111

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-08 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-059382.txt Sec File: edgar/data/1317493/0001144204-07-059382-index.htm

2007-11-07 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 1499 shares at $12.6581 remaining shares owned 35429

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-08 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-059382.txt Sec File: edgar/data/1317493/0001144204-07-059382-index.htm

2007-11-06 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 1894 shares at $12.14 remaining shares owned 36928

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-05 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-058239.txt Sec File: edgar/data/1317493/0001144204-07-058239-index.htm

2007-11-05 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 241 shares at $12.0525 remaining shares owned 38822

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-05 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-058239.txt Sec File: edgar/data/1317493/0001144204-07-058239-index.htm

2007-11-02 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 626 shares at $11.8772 remaining shares owned 39063

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-05 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-058239.txt Sec File: edgar/data/1317493/0001144204-07-058239-index.htm

2007-11-01 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 500 shares at $11.5009 remaining shares owned 39689

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4/a

Accession 0001144204-07-057584.txt Sec File: edgar/data/1317493/0001144204-07-057584-index.htm

2007-10-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 1066 shares at $12.4669 remaining shares owned 41936

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f4 the profit realized on the sale of 117 shares of the 1,066 sold is being remitted to the issuer. the 117 shares were originally purchased on june 20, 2007.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4/a

Accession 0001144204-07-057584.txt Sec File: edgar/data/1317493/0001144204-07-057584-index.htm

2007-10-30 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 996 shares at $12.0286 remaining shares owned 40940

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-11-01 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4/a

Accession 0001144204-07-057584.txt Sec File: edgar/data/1317493/0001144204-07-057584-index.htm

2007-10-31 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 751 shares at $11.6955 remaining shares owned 40189

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-10-31 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-057389.txt Sec File: edgar/data/1317493/0001144204-07-057389-index.htm

2007-10-31 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 751 shares at $11.6955 remaining shares owned 40189

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-10-31 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-057389.txt Sec File: edgar/data/1317493/0001144204-07-057389-index.htm

2007-10-30 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 996 shares at $12.0286 remaining shares owned 40940

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-10-31 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-057389.txt Sec File: edgar/data/1317493/0001144204-07-057389-index.htm

2007-10-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 1066 shares at $12.4669 remaining shares owned 41936

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-06-22 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-033209.txt Sec File: edgar/data/1317493/0001144204-07-033209-index.htm

2007-06-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc sold 117 shares at $7.3765 remaining shares owned 42885

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: S Open market or private sale of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f4 the sale was a result of an error and the profit realized on the purchase to offset the error is being remitted to the issuer.
f5 the number of shares reported in box 5 reflects a 1 for 8 reverse split which occurred on june 29, 2006.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.


Filed on 2007-06-22 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-07-033209.txt Sec File: edgar/data/1317493/0001144204-07-033209-index.htm

2007-06-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Idera Pharmaceuticals Inc bought 117 shares at $7.3 remaining shares owned 43002

Common Stock Idera Pharmaceuticals Inc Idp Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f4 the sale was a result of an error and the profit realized on the purchase to offset the error is being remitted to the issuer.
f5 the number of shares reported in box 5 reflects a 1 for 8 reverse split which occurred on june 29, 2006.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.